NU SKIN ENTERPRISES, INC. (NUS)

Every figure this model derived for NUS, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 40,027,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 191,386,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 508,149,000 AssetsCurrent 2026-06-30
current liabilities 256,347,000 LiabilitiesCurrent 2026-06-30
equity 542,739,000 StockholdersEquity 2026-06-30
interest expense 15,711,000 InterestExpenseNonoperating 2026-06-30
ocf 50,808,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,375,251,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 13,791,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NUS on one particular measure came for.

RatioValue
cash operating margin3.88
current ratio2.03
current ratio reported1.98
deferred revenue growth-14.86
dilution pct1.29
fcf margin0.78
interest cover-0.66
net debt ebitda0.72
operating margin-0.76
owner earnings margin-0.22
revenue growth-15.44
revenue growth per share-16.51
roic-1.44
rule of 40-16.19
sbc pct revenue1.0

What to be careful about

What this model itself distrusts about NUS's figures. Written by the derivation as it ran, not added afterwards.